Glucagon-like peptide 1 receptor agonists (GLP-1RA) have made waves as treatments for obesity and type 2 diabetes, but a new report suggests they might also have clinical benefits for certain patients ...

Electra Therapeutics has completed an oversubscribed $183 million Series C financing it said will fund a global pivotal trial of its lead pipeline candidate, a frontline treatment for secondary ...

Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...

Health care resource use increased in patients with Sjögren disease during the year after diagnosis, especially among those with comorbid autoimmune disorders.

The Lupus Foundation of America (LFA) celebrated exceptional lupus researchers at the 20th Anniversary Evelyn V. Hess ...

New results from Eli Lilly and Company and Incyte showed once-daily, oral baricitinib 4 mg helped the majority of adolescent ...

There are a number of reasons why toothpaste manufacturers would be instructed by the FDA to pull out (or voluntarily pull ...

Patients with PsA who are treated with CTT are not at a greater risk for serious or opportunistic infections compared with standard therapy.

Opioid prescribing appears to be prevalent among older adults with rheumatic diseases, according to results presented at the American College of Rheumatology (ACR) Convergence 2025.

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, announced today the acceptance of six abstracts at the 2025 American College of Rheumatology’s (ACR) annual meeting, ACR ...

RVO Health’s Suzy Jackson joins us to talk about its new digital health division and what “direct-to-patient” really means for the patient experience.

In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear ...